Stock listing

Avantor, Inc.

Selected listing: AVTR · VIE · EUR · AT

Avantor, Inc. (Vienna:AVTR), Health Technology. Latest release Oct 1, 2026: Avantor® to Report Third Quarter 2026 Earnings on Wednesday, October 28, 2026.

AVTR:VIEEURATUpdated October 2, 2026

Ticker: Vienna:AVTR
Asset type: Stock
Sector: Health Technology
Industry: Medical Specialties
Exchange: Vienna
Currency: EUR

About Avantor, Inc.

Avantor, Inc. is a public company traded under the ticker AVTR in the American market. The company focuses on enhancing the efficiency and effectiveness of research and production processes for its clients.

Latest news from Avantor, Inc.

Avantor® to Report Third Quarter 2026 Earnings on Wednesday, October 28, 2026

October 1, 2026

Avantor appoints new Chief Financial Officer

September 21, 2026

Avantor® Reports Second Quarter 2026 Results

July 29, 2026

Avantor's® NuSil® Brand Expands Partnership with the Population Council to Develop Long-Acting HIV Prevention Product

July 14, 2026

Cell Culture Media Market worth $12.9 billion by 2033: Biologics Manufacturing and Cell Therapy Expansion Accelerate Growth for Avantor, Thermo Fisher Scientific, and Lonza Group AG

July 8, 2026

All Avantor, Inc. news →

Events

Replays

Avantor, Inc. (AVTR) Q2 2026 Earnings Call
Wed, Jul 29, 2026 · 08:00 AM ET
Watch
Avantor, Inc. (AVTR) Q1 2026 Earnings Call
Wed, Apr 29, 2026 · 08:00 AM ET
Watch
Avantor, Inc. (AVTR) Q4 2025 Earnings Call
Wed, Feb 11, 2026 · 08:00 AM ET
Watch

Research Avantor, Inc.

Avantor, Inc. company profile

View the public company page for Avantor, Inc. on 6ix.

Avantor, Inc. news

Read company news and market updates connected to Avantor, Inc..

Avantor, Inc. investor events

Find investor webinars, events, and replay context for Avantor, Inc..